![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Victoria Divino, Jennifer Schranz, Maureen Early, Hemal Shah, Miao Jiang & Mitch DeKoven. (2020) The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study. Current Medical Research and Opinion 36:1, pages 151-160.
Read now
Read now
Alpesh N. Amin, Elizabeth A. Cerceo, Steven B. Deitelzweig, James C. Pile, David J. Rosenberg & Bradley M. Sherman. (2014) The Hospitalist Perspective on Treatment of Community–Acquired Bacterial Pneumonia. Postgraduate Medicine 126:2, pages 18-29.
Read now
Read now
Stefano Aliberti & Keith S. Kaye. (2013) The Changing Microbiologic Epidemiology of Community-Acquired Pneumonia. Postgraduate Medicine 125:6, pages 31-42.
Read now
Read now
Articles from other publishers (15)
Joan-Miquel Balada-Llasat, Nicole Stamas, Tom Vincent, Tristan T. Timbrook, Cynthia Saiontz-Martinez, Rachael B. Hemmert & Ariel Berger. (2022) Epidemiology and Economic Outcomes Associated with Timely versus Delayed Receipt of Appropriate Antibiotic Therapy among US Patients Hospitalized for Native Septic Arthritis: A Retrospective Cohort Study. Antibiotics 11:12, pages 1732.
Crossref
Crossref
Morganne A. Sindelar, Anne E. Zepeski, Brooke J. Lawler, Stephanie D. Johnston & Brett A. Faine. (2022) MRSA nasal swab PCR to de-escalate antibiotics in the emergency department. The American Journal of Emergency Medicine 55, pages 133-137.
Crossref
Crossref
S.N. Avdeev, V.B. Beloborodov, B.Z. Belotserkovskiy, A.I. Gritsan, A.V. Dekhnich, A.A. Zaytsev, M.Yu. Kirov, R.S. Kozlov, V.V. Kuzkov, D.N. Protsenko, S.A. Rachina, A.I. Sinopalnikov, S.V. Yakovlev & A.I. Yaroshetskiy. (2022) Severe community-acquired pneumonia in adults. Clinical recommendations from Russian Federation of Anaesthesiologists and Reanimatologists. Anesteziologiya i reanimatologiya:1, pages 6.
Crossref
Crossref
Erin B. Brazel, Aimee Tan, Stephanie L. Neville, Amy R. Iverson, Saumya R. Udagedara, Bliss A. Cunningham, Mwilye Sikanyika, David M.P. De Oliveira, Bernhard Keller, Lisa Bohlmann, Ibrahim M. El-Deeb, Katherine Ganio, Bart A. Eijkelkamp, Alastair G. McEwan, Mark von Itzstein, Megan J. Maher, Mark J. Walker, Jason W. Rosch & Christopher A. McDevitt. (2022) Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model. Cell Reports 38:2, pages 110202.
Crossref
Crossref
Xiwen Du, Yi Han, Yifei Jian, Liping Chen & Jianwei Xuan. (2021) Clinical Benefits and Cost-Effectiveness of Moxifloxacin as Initial Treatment for Community-Acquired Pneumonia: A Meta-Analysis and Economic Evaluation. Clinical Therapeutics 43:11, pages 1894-1909.e1.
Crossref
Crossref
VandanaKalwaje Eshwara, Chiranjay Mukhopadhyay & Jordi Rello. (2020) Community-acquired bacterial pneumonia in adults: An update. Indian Journal of Medical Research 151:4, pages 287.
Crossref
Crossref
Carmen Andrea Pfortmueller, Maria Teresa Barbani, Joerg Christian Schefold, Elias Hage, Albert Heim & Stefan Zimmerli. (2019) Severe acute respiratory distress syndrome (ARDS) induced by human adenovirus B21: Report on 2 cases and literature review. Journal of Critical Care 51, pages 99-104.
Crossref
Crossref
Susanne Paukner, Steven P. Gelone, S. J. Ryan Arends, Robert K. Flamm & Helio S. Sader. (2019) Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015–2016). Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Crossref
Nicole Gidaya Bonine, Ariel Berger, Arman Altincatal, Rosa Wang, Tarun Bhagnani, Patrick Gillard & Thomas Lodise. (2019) Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections. The American Journal of the Medical Sciences 357:2, pages 103-110.
Crossref
Crossref
Sandeep Nayar, Ashfaq Hasan, Pradyut Waghray, Srinivasan Ramananthan, Jaishid Ahdal & Rishi Jain. (2019) Management of community-acquired bacterial pneumonia in adults: Limitations of current antibiotics and future therapies. Lung India 36:6, pages 525.
Crossref
Crossref
Bin Cao, Yi Huang, Dan‐Yang She, Qi‐Jian Cheng, Hong Fan, Xin‐Lun Tian, Jin‐Fu Xu, Jing Zhang, Yu Chen, Ning Shen, Hui Wang, Mei Jiang, Xiang‐Yan Zhang, Yi Shi, Bei He, Li‐Xian He, You‐Ning Liu & Jie‐Ming Qu. (2017) Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. The Clinical Respiratory Journal 12:4, pages 1320-1360.
Crossref
Crossref
June Utnes Høgli, Beate Hennie Garcia, Frode Skjold, Vegard Skogen & Lars Småbrekke. (2016) An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital. BMC Infectious Diseases 16:1.
Crossref
Crossref
Scott T Micek, Adam Lang, Brian M Fuller, Nicholas B Hampton & Marin H Kollef. (2014) Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department. BMC Infectious Diseases 14:1.
Crossref
Crossref
D. Thellier, H. Georges & O. Leroy. (2014) Quels prélèvements aux urgences pour le diagnostic microbiologique d’une infection pulmonaire communautaire grave du sujet immunocompétent ?Which samples to obtain in the emergency department for the microbiological diagnosis of community-acquired pneumonia in the immunocompetent patient?. Réanimation 23:5, pages 490-497.
Crossref
Crossref
Stefano Aliberti & Paola Faverio. 2014. Community-Acquired Pneumonia. Community-Acquired Pneumonia
205
218
.